Literature DB >> 29934015

Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy<sup/>.

Adam Hartley1, Dorian Haskard1, Ramzi Khamis2.   

Abstract

We provide an up-to-date overview of current topics surrounding oxidized low-density lipoprotein (oxLDL) and its related antibodies in the quest to better identify the individuals at risk of cardiovascular disease and atherosclerotic plaques with unfavorable characteristics. We discuss the potential of oxLDL and anti-oxLDL antibodies as serum biomarkers of cardiovascular disease and emerging studies examining the targeting of arterial oxLDL for imaging and therapeutic delivery.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Atherosclerosis; Oxidized low-density lipoprotein; Vulnerable plaque

Mesh：

Substances：

Year:  2018        PMID： 29934015     DOI： 10.1016/j.tcm.2018.05.010

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


  36 in total

Review 1.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

Review 2.  Oxidative Stress Parameters as Biomarkers of Cardiovascular Disease towards the Development and Progression.

Authors:  Amanda Shen-Yee Kong; Kok Song Lai; Cheng-Wan Hee; Jiun Yan Loh; Swee Hua Erin Lim; Maran Sathiya
Journal:  Antioxidants (Basel)       Date:  2022-06-15

3.  Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.

Authors:  Naoko Sawada; Takashi Obama; Shinji Koba; Takashi Takaki; Sanju Iwamoto; Toshihiro Aiuchi; Rina Kato; Masaki Kikuchi; Yuji Hamazaki; Hiroyuki Itabe
Journal:  J Lipid Res       Date:  2020-04-14       Impact factor: 5.922

4.  Antibody to oxidized low-density lipoprotein inhibits THP1 cells from apoptosis by suppressing NF-κB pathway activation.

Authors:  Rui Dai; Jing Dong; Weijuan Li; Yi Zhou; Wei Zhou; Wenping Zhou; Manhua Chen
Journal:  Cardiovasc Diagn Ther       Date:  2019-08

5.  IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).

Authors:  Victor J van den Berg; Dorian O Haskard; Artur Fedorowski; Adam Hartley; Isabella Kardys; Mikhail Caga-Anan; K Martijn Akkerhuis; Rohit M Oemrawsingh; Robert Jan van Geuns; Peter de Jaegere; Nicolas van Mieghem; Evelyn Regar; Jurgen M R Ligthart; Victor A W M Umans; Patrick W Serruys; Olle Melander; Eric Boersma; Ramzi Y Khamis
Journal:  EBioMedicine       Date:  2018-08-18       Impact factor: 8.143

Review 6.  Modulation of the Gut Microbiota by Olive Oil Phenolic Compounds: Implications for Lipid Metabolism, Immune System, and Obesity.

Authors:  Marta Farràs; Laura Martinez-Gili; Kevin Portune; Sara Arranz; Gary Frost; Mireia Tondo; Francisco Blanco-Vaca
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

Review 7.  A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels.

Authors:  Takanari Nakano; Ikuo Inoue; Takayuki Murakoshi
Journal:  Nutrients       Date:  2019-02-01       Impact factor: 5.717

8.  Cardiotonic Pills Plus Recombinant Human Prourokinase Ameliorates Atherosclerotic Lesions in LDLR-/- Mice.

Authors:  Jing-Na Deng; Quan Li; Kai Sun; Chun-Shui Pan; Huan Li; Jing-Yu Fan; Gao Li; Bai-He Hu; Xin Chang; Jing-Yan Han
Journal:  Front Physiol       Date:  2019-09-10       Impact factor: 4.566

9.  MicroRNA-30-3p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21.

Authors:  Zhenyu Zhou; Yu Chen; Dongying Zhang; Shiyong Wu; Tao Liu; Guoqiang Cai; Shu Qin
Journal:  Mediators Inflamm       Date:  2019-07-02       Impact factor: 4.711

10.  Propofol Ameliorates ox-LDL-Induced Endothelial Damage Through Enhancing Autophagy via PI3K/Akt/m-TOR Pathway: A Novel Therapeutic Strategy in Atherosclerosis.

Authors:  Hongyi Zhou; Fan Jiang; Yufang Leng
Journal:  Front Mol Biosci       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.